| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $156.8M | +3.2% | +19.5% |
| Cost of Revenue | $161.4M | +7.3% | +30.5% |
| R&D Expense | $167.1M | +9.9% | +19.6% |
| SG&A Expense | $188.4M | +13.9% | +26.5% |
| Pre-tax Income | $148.6M | +32.4% | +132.6% |
| Income Tax | $9.2M | -38.6% | +194.5% |
| Net Income | $139.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.25B | +52.9% | +37.9% |
| Total Assets | $45.29B | +10.2% | +31.7% |
| Total Liabilities | $36.51B | +6.6% | +29.2% |
| Stockholders' Equity | $8.78B | +28.0% | +43.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.75B | — | — |
| Investing Cash Flow | -$4.62B | — | — |
| Financing Cash Flow | $8.41B | — | — |
| +43.3% |
| +129.5% |
| EPS (Basic) | $0.12 | +33.3% | +100.0% |
| EPS (Diluted) | $0.11 | +37.5% | +120.0% |